Abstract
Electrocardiograms (ECG) and enzyme criteria are usually used to confirm the diagnosis of acute myocardial infarction in the case of chest pain. However, ECG is not always diagnostic. Elevated enzyme values may be due to causes other than myocardial infarction. In uncertain cases, the ECG and enzyme criteria can be supplemented by emission tomography, performed with technetium pyrophosphate that will accumulate in the site of infarction. Twenty-nine patients with suspected acute myocardial infarction were studied with emission tomography. Of these 12 had acute transmural infarction. Both enzyme tests and ECG were diagnostic in only 7 of these 12 cases, 4 had positive enzyme tests but a nondiagnostic ECG and in one case neither enzymes nor ECG were diagnostic. In 11 patients the infarcted myocardial area was detected with emission tomography. Six patients had acute nontransmural infarction. Only 2 of these had positive emission tomography. The chest pain was not due to infarction in 11 patients. All these patients had negative emission tomography. The sensivitity of emission tomography was 92% and specificity 100% in transmural acute infarction. In nontransmural infarction the specificity was only 33%. Emission tomography is a valuable diagnostic tool. It may be the decisive method when ECG and enzymes are not diagnostic. Emission tomography also shows the localization and size of the infarcted area in the myocardium.
Similar content being viewed by others
References
Abdullah AZ, Stone DL, Britton KE, Elliot AT (1981) Emission computerized tomography with 99mTc-pyrophosphate in myocardial infarction. Nucl Med Commun 2:140–146
Bonte FJ, Parkey RW, Graham KD, Moore JG (1975) Distributions of several agents useful in imaging myocardial infarcts. J Nucl Med 16:132–135
Holman BL, Goldhaber SZ, Kirsch CM, Polak JF, Friedman BJ, English RJ (1982) Measurement of infarct size using single photon emission tomography and technetium 99m pyrophosphate: a description of the method and comparison with patient prognosis. Am J Cardiol 50:503–511
Lewis SE, Stokely EM, Devous Sr MD, Bonte FJ, Buja LM, Parkey RW, Willerson JT (1981) Quantitation of experimental canine infarct size with multipinhole and rotating slanthole tomography. J Nucl Med 22:1000–1005
Lott JA, Stang JM (1980) Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis. Clin Chem 26:1241–1250
Lyons KP, Olson HG, Aronow WS (1980) Pyrophosphate myocardial imaging. Semin Nucl Med 10:168–177
Massie BM, Botvinick EH, Werner JA, Chatterjee K, Parmley WW (1979) Myocardial scintigraphy with technetium-99m stannous pyrophosphate: an insensitive test for nontransmural myocardial infarction. Am J Cardiol 43:186–192
Parkey RW, Bonte FJ, Buja LM, Stokely EM, Willerson JT (1977) Myocardial infarct imaging with technetium-99m phosphate. Semin Nucl Med 7:15–28
Schelbert HR, Hentze E, Wisenberg G (1981) Imaging with infarctavid agents. CRC Crit Rev Diagn Imaging 16:239–278
Willerson JT, Parkey RW, Bonte FJ, Lewis SE, Corbett J, Buja M (1980) Pathophysiologic considerations and clinicopathological correlates of technetium-99m stannous pyrophosphate myocardial scintigraphy. Semin Nucl Med 10:54–69
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pöyhönen, L., Uusitalo, A. & Virjo, A. Emission tomography with 99mTc-pyrophosphate in the diagnosis of acute myocardial infarction. Eur J Nucl Med 10, 489–493 (1985). https://doi.org/10.1007/BF00252739
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00252739